ICE-T Symposium

Immune Cellular Effector Therapies

Next ICE-T: Orlando, 7/26/25

Why Attend?

Engage with leading experts and peers shaping the future of cellular therapy

Explore breakthrough research and evolving treatment paradigms
Gain practical insights you can bring back to your clinic

Bonus:

It’s a long weekend in Orlando—so bring the family!

After the conference, unleash your inner child (or wizard) at Disney or Universal. Whether you’re all about magic, Marvel, or molecules—no judgment here!

Don’t miss this unique blend of science and fun. Register now and secure your spot!

Signia by Hilton Bonner Creek, Orlando, FL
Register Here
Special Hotel Rates
Questions?

HOTEL

Contact CE Office

Course Directors

Nausheen Ahmed

Al-Ola Abdallah

Zahra Mahmoudjafari

Speakers and Panelists

Full Agenda

Updates of T Cell Engagers in Myeloma

Shebli Atrash, MD, Clinical Professor of Medicine, University of Wake Forest

Advances of CAR-T Therapies in Myeloma

Barry Paul, MD, University of Wake Forest

Management of Adverse Event of CAR-T and T- Cell Engagers in Myeloma

Syeda Saba Kareem, PharmD

Current and Future Developments of Cell Therapies in Melanoma

Muhammad Umair Mushtaq, MD - Associate Professor, University of Kansas Cancer Center

Developments of Cell Therapies in Pancreatic Cancer

Anup Kasi, MD, MPH - Associate Professor, Division of Medical Oncology, University of Kansas Cancer Center, Kansas City, Kansas

Developments of T-Cell Engagers Therapies in Lung Cancer

Daniel Carrizosa, MD, Clinical Associate Professor of Hematology and Oncology at the Wake Forest School of Medicine

Revolutionizing Lymphoma Treatment: The Latest Breakthrough in CAR-T Therapy

Jose Sandoval-Sus, MD, FACP - Associate member, Department of Malignant Hematology, Moffitt cancer center at Memorial Healthcare System.

T-Cell Engagers Unleashed: Cutting-Edge Advances in Lymphoma Therapy

Marc Hoffmann, MD - Associate Professor of Medicine, Director of Lymphoma Program, University of Kansas Medical Center

Mastering the Management of Adverse Effects from Cellular Therapies in Lymphoma

Tiba Al Sagheer, PharmD

Lymphoma Panel Modeerator

Forat Lutfi, MD - Assistant Professor, Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center

Expert Strategies for Managing Neurotoxicity in T Cell Engagers and CAR-T Therapy (Virtual Presentation)

Muhammad M. Nashatizadeh, MD, Clinical Assistant Professor, Department of Neurology - University of Kansas School of Medicine

Dynamic Infection Management Tactics in T Cell Engagers and CAR-T Cell Therapy

Aneela Majeed, MD, Infectious Diseases, Cleveland Clinic Foundation

Pioneering Cellular Therapies Transforming Treatment for ALL

Sunil Abhyankar, MD, Professor of Medicine, Medical Director, Pheresis and Cell Processing Position, Director, Midwest Stem Cell Therapy Center, University of Kansas Medical Center

Navigating the Challenges: Managing Adverse Effects of Cellular Therapies in ALL

Rebecca Gonzalez, PharmD, BCOP, FASTCT - Moffitt Cancer Center

Panelist/Moderator:Myeloma

Al-Ola Abdallah, MD, Associate Professor, Director of Plasma Cell Disorder Clinic, University of Kansas Cancer Center

Panel Discussion: Leukemia and Supportive Care

Nausheen Ahmed, MD - Associate Professor, Associate Director of Cellular Therapeutics, University of Kansas Cancer Center

Panelist/Moderator: Solid Tumors

Zahra Mahmoudjafari, PharmD, MBA - University of Kansas Health System

Innovation. Connection. Collaboration.

Born from a simple yet powerful realization—no therapy is truly transformative unless it reaches the patient—the ICE-T (Immune Cell Effector Therapies) Symposium was created to bridge the widening gap between innovation and access. As revolutionary treatments like CAR-T cells, bispecifics, tumor-infiltrating lymphocytes (TILs), and gene therapies emerged, their promise extended far beyond hematologic cancers, reshaping the treatment landscape for solid tumors and autoimmune diseases alike. But while the science surged ahead, a critical divide remained: therapies often reached the academic bedside but not the patient’s home. ICE-T was envisioned as the conduit—where cutting-edge science meets community care. A collaboration between Dr Nausheen Ahmed, Dr Al-Ola Abdallah and Dr Zahra Mahmoudjafari, the inaugural symposium launched in Kansas City in 2024 with a singular mission: to unite academic and community oncologists, advanced practice providers, pharmacists, nurses, and allied professionals in a shared commitment—to bring life-saving immunotherapies not just from bench to bedside, but from cancer centers to communities.

ICE-T Kansas City 2024 memories

CORTEX

ICE-T Symposium

Next ICE-T: Orlando, 7/26/25

Signia by Hilton Bonner Creek, Orlando, FL
Register Here
Special Hotel Rates
Questions?

Course Directors

Speakers and Panelists

Become a Part of Our Mission

CORTEX

ICE-T Symposium

Next ICE-T: Orlando, 7/26/25

Signia by Hilton Bonner Creek, Orlando, FL Register Here Special Hotel Rates Questions?

Course Directors

Speakers and Panelists

Become a Part of Our Mission

Signia by Hilton Bonner Creek, Orlando, FL
Register Here
Special Hotel Rates
Questions?